Evaluating Newly Approved Drugs for Multidrug-resistant TB

计划入组 754 人 · 首次发布于 2016 年 4 月 28 日

Evaluating a new treatment regimen for patients with multidrug-resistant TB (MDR-TB)

计划入组 256 人

ENDTB - 2

计划入组 287 人

Bedaquiline(Sirturo)

C₃₂H₃₁BrN₂O₂ · Rx

TB-003B

TB-100

THE GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT INC INCORPORATED IN THE STATE OF DELAWARE USA

South Africa

Global Alliance for TB Drug Development

United States

FREUNDESKREIS FUR INTERNATIONALE TUBERKULOSEHILFE E.V (FIT)

Vietnam

Bedaquiline's Effectiveness Against Drug-Resistant TB Linked to Enzyme Deficiencies

Bill Gates Optimistic About Progress in M72 Tuberculosis Vaccine Clinical Trial

Shorter Bedaquiline Regimens Show Sustained Efficacy Against Rifampicin-Resistant TB